Michel Hasselmann

Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: The CRYSTMAS study

Bertrand Guidet, Olivier Martinet, Thierry Boulain et al. · Critical Care · 2012 · 341 citations · Full text

Hemodynamic Efficacy, Severe Sepsis, Patient Safety +6

L-alanyl-L-glutamine dipeptide–supplemented total parenteral nutrition reduces infectious complications and glucose intolerance in critically ill patients: The French controlled, randomized, double-blind, multicenter study*

Pierre Déchelotte, Michel Hasselmann, Luc Cynober et al. · Critical Care Medicine · 2006 · 327 citations

A randomized trial of supplemental parenteral nutrition in underweight and overweight critically ill patients: the TOP-UP pilot trial

Paul E. Wischmeyer, Michel Hasselmann, Christine Kummerlen et al. · Critical Care · 2017 · 155 citations · Full text

Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: The CRYSTMAS study

Bertrand Guidet, Olivier Martinet, Thierry Boulain et al. · Critical Care · 2012 · 143 citations · Full text

Severe Sepsis, Fluid Resuscitation, Nephrology +16

Methylene blue increases systemic vascular resistance in human septic shock

Francis Schneider, Ph. Lutun, Michel Hasselmann et al. · Intensive Care Medicine · 1992 · 134 citations

Inflammation, Medicine, Physiology +6